Contrast Associated Acute Kidney Injury (CA-AKI): Update

Visit for more related articles at Journal of Nephrology and Urology


In recent literature, the frequency of Contrast Associated Acute Kidney Injury (CA-AKI) after primary percutaneous coronary intervention (PCI) is reported to range from 10.4% to 23.2%. CA-AKI after primary PCI can lead to 4 to 8 fold increased risk of in-hospital mortality. Intravenous iodinated contrast media (ICM) are commonly used with CT to evaluate disease & to determine treatment response. Although patients have benefited from their use, CM historically have been denied or delayed in pts with ↓ kidney function due to the perceived risks of AKI. This is important because denying patients diagnostic testing that is indicated in a timely fashion creates potential for indirect harm related to delayed diagnosis & misdiagnosis. Because of the critical role CM play in modern medical imaging, clinicians & radiologists are routinely charged with balancing the potential risks of CM with diagnostic benefits. Clinical decision making in pts potentially at risk for AKI is often fraught with confusion, uncertainty, & heterogeneity. The data will be mentioned in this presentation should be considered in the context of the entire clinical scenario.

Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article